CARE
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 69 | +7 | 10.63M | $361.24M | +12 | −5 |
| Q1 2026 | 64 | +4 | 8.00M | $186.46M | +5 | −1 |
| Q4 2025 | 60 | 0 | 7.81M | $153.57M | n/a | n/a |
| Q3 2025 | 16 | 0 | 4.93M | $95.79M | n/a | n/a |
| Q2 2025 | 13 | 0 | 4.47M | $77.57M | +1 | −1 |
| Q1 2025 | 10 | +1 | 1.58M | $25.61M | +1 | n/a |
| Q4 2024 | 9 | +1 | 1.60M | $28.10M | +1 | n/a |
| Q3 2024 | 7 | 0 | 1.04M | $18.13M | n/a | n/a |
| Q2 2024 | 7 | n/a | 996.51K | $15.07M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 505.48K | n/a | $7.64M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Citadel Advisors ✦ | 100.34K | n/a | $1.52M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Arrowstreet Capital ✦ | 98.09K | n/a | $1.48M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 83.51K | n/a | $1.26M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 83.10K | n/a | $1.26M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 76.64K | n/a | $1.16M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 49.34K | n/a | $746,096 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 124 holders, 12.68M shares, $291.56M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 1.00K sh · $31,250
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology